Sign Out
Pregnancy: Rituximab can cross the placenta and may affect the baby; therefore, physician should be informed if pregnant, might be pregnant or planning to become pregnant.
Breastfeeding: Patient should not breastfeed while being treated with Rituximab. Also, patient must not breastfeed for 12 months after the last treatment with Rituximab. This may pass into the breast milk.
Continue with Google